Iladatuzumab (MCDS0593A) (CAS: 1906205-76-2)
Iladatuzumab is a monoclonal antibody targeting CD79B, used in the development of antibody-drug conjugates (ADCs) for treating B-cell cancers, especially B-cell non-Hodgkin lymphoma (B-NHL).
Key Features:
- Target: Binds to CD79B on mature B cells.
- Use: Part of ADCs like iladatuzumab vedotin (DCDS0780A) for B-NHL treatment.
Applications:
- Cancer Research: Used to create ADCs for B-NHL research.
- ADC Development: Helps deliver cytotoxic drugs directly to B-cell cancers.
Handling and Storage:
- Storage: Store at 2-8°C for short-term use or at -20 to -80°C for long-term storage.
- Precautions: Use appropriate protective equipment.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
